Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Larimar Therapeutics, Inc. (LRMR)
USD3.70
-0.03 (-0.67%)
US NASDAQ Healthcare Biotechnology
Address
Three Bala Plaza East 19004
Bala Cynwyd, PA, US
Bala Cynwyd, PA, US
CEO
Carole S. Ben-Maimon
Website
larimartx.com
IPO
2014-06-19
CIK 1374690 ISIN US5171251003
Description
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.70
-0.03 (-0.67%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.82
Float Shares
51.16M
Free Float %
59.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.12% | -3.23% | -20.12% | +23.49% | +15.09% | +2.10% | +117.32% | +8.36% | -70.91% | -95.18% | -98.36% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (8 ratings, all time)
Buy
Price Targets & DCF
Current price
3.70
Low
12.00
+224.8%
Consensus
12.00
+224.8%
Median
12.00
+224.8%
High
12.00
+224.8%
DCF (Unlevered)
1.06
-71.4%
DCF (Levered)
1.12
-69.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 10 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
12.00
+224.8%
|
| Last Year | 2 |
9.50
+157.1%
|
| All Time | 7 |
14.14
+282.7%
|
Quality scores
Altman Z-Score
-0.96
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-72.0% Q1'26: +100.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+19.1% Q1'26: -100.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02× Q1'26: -0.03× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 6 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
2.32M
480.1K – 6.02M
|
62.82M
14.62M – 125.52M
+2,611.7% YoY
|
155.72M
155.72M – 155.72M
+147.9% YoY
|
268.59M
55.66M – 698.10M
+72.5% YoY
|
383.41M
79.46M – 996.57M
+42.8% YoY
|
| EBITDA |
-90.57M
|
-172.50M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-90.89M
|
-172.50M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-80.60M
est: -74.37M (-8.4%)
|
-165.67M
est: -136.78M (-21.1%)
|
-193.77M
-223.30M – -104.46M
-41.7% YoY
|
-119.20M
-162.80M – -75.61M
+38.5% YoY
|
-58.86M
-141.01M – 74.61M
+50.6% YoY
|
-10.94M
-33.69M – 334.8K
+81.4% YoY
|
44.86M
-1.37M – 138.13M
+510.0% YoY
|
| SGA |
17.61M
|
18.27M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.32
est: -1.21 (-9.2%)
|
-2.27
est: -1.95 (-16.3%)
|
-1.97
-3.06 – -1.43
-1.0% YoY
|
-1.49
-2.23 – -1.04
+24.4% YoY
|
-0.79
-1.93 – 1.02
+46.7% YoY
|
-0.15
-0.46 – 0.00
+81.1% YoY
|
0.62
-0.02 – 1.89
+510.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
36
Total invested
19.76M
Insider transactions (90d)
0
Beneficial owners (>5%)
39
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter Kolchinsky | 6.05M | 9.50% | — | 6.05M | — | 6.05M | HC, IN | Delaware | 2024-02-26 | ↗ |
| 2 | RA Capital Healthcare Fund, L.P. | 6.05M | 9.50% | — | 6.05M | — | 6.05M | PN | Delaware | 2024-02-26 | ↗ |
| 3 | RA Capital Management, L.P. | 6.05M | 9.50% | — | 6.05M | — | 6.05M | IA, PN | Delaware | 2024-02-26 | ↗ |
| 4 | Rajeev Shah | 6.05M | 9.50% | — | 6.05M | — | 6.05M | HC, IN | Delaware | 2024-02-26 | ↗ |
| 5 | Deerfield Management Company, L.P. | 5.15M | 33.50% | — | 5.15M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 6 | James E. Flynn | 5.15M | 33.50% | — | 5.15M | — | 10.00 | IN | United States of America | 2021-05-26 | ↗ |
| 7 | GOLDMAN SACHS & CO. LLC | 4.49M | 7.00% | — | — | 4.49M | 4.49M | BD, IA, OO | — | 2024-11-06 | ↗ |
| 8 | THE GOLDMAN SACHS GROUP, INC. | 4.49M | 7.00% | — | — | 4.49M | 4.49M | HC, CO | — | 2024-11-06 | ↗ |
| 9 | Blue Owl Capital Holdings LP | 3.41M | 7.78% | 3.41M | — | 3.41M | — | PN | Delaware | 2024-02-14 | ↗ |
| 10 | Advisors LLC | 2.86M | 6.60% | — | 2.86M | — | 2.86M | IA | — | 2023-02-14 | ↗ |
| 11 | Edelman | 2.86M | 6.60% | — | 2.86M | — | — | IN | — | 2023-02-14 | ↗ |
| 12 | Sciences Master Fund, Ltd. | 2.86M | 6.60% | — | 2.86M | — | — | CO | — | 2023-02-14 | ↗ |
| 13 | Sphera Funds Management Ltd. | 2.84M | 7.59% | — | 2.84M | — | — | CO | Israel | 2020-02-11 | ↗ |
| 14 | Nicholas Maounis | 2.81M | 6.40% | — | 2.81M | — | 2.81M | HC, IN | Delaware | 2024-02-14 | ↗ |
| 15 | Verition Fund Management LLC | 2.81M | 6.40% | — | 2.81M | — | 2.81M | IA, OO | Delaware | 2024-02-14 | ↗ |
| 16 | 00-0000000 | 2.19M | 5.10% | — | 2.19M | — | 2.19M | CO | Cayman Islands | 2023-08-18 | ↗ |
| 17 | EIN #00-0000000 | 2.19M | 5.10% | — | 2.19M | — | 2.19M | IA, HC | Jersey, Channel Islands | 2023-08-18 | ↗ |
| 18 | Deerfield Mgmt, IV, L.P. | 1.71M | 11.16% | — | 1.71M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 19 | Deerfield Private Design Fund IV, L.P. | 1.71M | 11.16% | — | 1.71M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 20 | Deerfield Healthcare Innovations Fund, L.P. | 1.71M | 11.16% | — | 1.71M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 21 | Deerfield Mgmt HIF, L.P. | 1.71M | 11.16% | — | 1.71M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 22 | Deerfield Mgmt III, L.P. | 1.71M | 11.16% | — | 1.71M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 23 | Deerfield Private Design Fund III, L.P. | 1.71M | 11.16% | — | 1.71M | — | 10.00 | PN | Delaware | 2021-05-26 | ↗ |
| 24 | CHI Advisors LLC | 1.52M | 8.56% | 1.52M | — | — | — | IA | Delaware | 2022-02-11 | ↗ |
| 25 | I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | 943.7K | 5.32% | — | 943.7K | — | 943.7K | CO | MA | 2022-02-18 | ↗ |
| 26 | OrbiMed Capital LLC | 732.3K | 4.77% | 732.3K | — | 732.3K | — | IA | Delaware | 2021-02-12 | ↗ |
| 27 | Vivo Opportunity, LLC | 326.9K | 1.80% | 326.9K | — | 326.9K | — | OO | Delaware | 2022-02-11 | ↗ |
| 28 | Arsani William | 300.0K | 11.00% | — | 300.0K | — | 300.0K | HC, IN | Delaware | 2021-02-16 | ↗ |
| 29 | Logos GP LLC | 300.0K | 11.00% | — | 300.0K | — | 300.0K | OO | Delaware | 2021-02-16 | ↗ |
| 30 | Logos Global Management GP LLC | 300.0K | 11.00% | — | 300.0K | — | 300.0K | HC, OO | Delaware | 2021-02-16 | ↗ |
| 31 | Logos Global Management LP | 300.0K | 11.00% | — | 300.0K | — | 300.0K | IA, PN | Delaware | 2021-02-16 | ↗ |
| 32 | Logos Global Master Fund LP | 300.0K | 11.00% | — | 300.0K | — | 300.0K | PN | Delaware | 2021-02-16 | ↗ |
| 33 | 13-3127734 | 221.4K | 1.44% | 195.8K | — | 221.4K | — | HC | Delaware | 2021-02-11 | ↗ |
| 34 | 26-0385758 | 221.4K | 1.44% | 195.8K | — | 221.4K | — | IA | Delaware | 2021-02-11 | ↗ |
| 35 | Sio Capital Management, LLC 20-4586565 | 188.7K | 1.23% | — | 188.7K | — | 188.7K | IA | — | 2021-02-16 | ↗ |
| 36 | OrbiMed Advisors LLC | 154.2K | 1.00% | — | 154.2K | — | — | IA | Delaware | 2021-02-12 | ↗ |
| 37 | Vivo Capital IX, LLC | 72.9K | 0.40% | 72.9K | — | 72.9K | — | OO | Delaware | 2022-02-11 | ↗ |
| 38 | Acuta Capital Partners, LLC | — | 11.00% | — | — | — | — | IA, OO | Delaware | 2022-02-15 | ↗ |
| 39 | Anupam Dalal | — | 11.00% | — | — | — | — | HC, IN | Delaware | 2022-02-15 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
36
-100 vs prev Q
New positions
6
Closed positions
104
Increased
21
Reduced
7
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 30.61M +— (+0.0%) | 116.61M +17.8M (+18.0%) | 39.08% -8.726 pp | 1.49% -0.020 pp | USD5.58 -31.7% | 23 qtrs — |
| 2 | BLUE OWL CAPITAL HOLDINGS LP | 6.82M +970.7K (+16.6%) | 26.00M +7.1M (+37.5%) | 8.71% -0.429 pp | 1.95% -3.923 pp | USD4.47 -14.8% | 9 qtrs — |
| 3 | MILLENNIUM MANAGEMENT LLC | 5.21M +309.5K (+6.3%) | 19.84M +4.0M (+25.4%) | 6.65% -1.001 pp | 0.01% +0.002 pp | USD3.20 +19.1% | 8 qtrs — |
| 4 | BLACKROCK, INC. | 3.68M +342.4K (+10.3%) | 14.03M +3.2M (+30.1%) | 4.70% -0.515 pp | 0.00% +0.000 pp | USD5.83 -34.6% | 6 qtrs — |
| 5 | RTW INVESTMENTS, LP | 3.13M +— (+0.0%) | 11.91M +1.8M (+18.0%) | 3.99% -0.891 pp | 0.12% -0.005 pp | USD3.23 +18.0% | 2 qtrs — |
| 6 | VANGUARD GROUP INC | 3.05M -41.6K (-1.3%) | 11.61M +1.6M (+16.4%) | 3.89% -0.933 pp | 0.00% +0.000 pp | USD6.17 -38.2% | 23 qtrs — |
| 7 | AIGH CAPITAL MANAGEMENT LLC | 2.00M +1.0M (+100.0%) | 7.62M +4.4M (+135.9%) | 2.55% +0.992 pp | 1.84% +0.934 pp | USD3.52 +8.2% | 2 qtrs — |
| 8 | POINT72 ASSET MANAGEMENT, L.P. | 1.46M +237.2K (+19.4%) | 5.57M +1.6M (+40.8%) | 1.87% -0.046 pp | 0.01% 0.000 pp | USD3.32 +14.8% | 2 qtrs — |
| 9 | CITADEL ADVISORS LLC | 1.37M -110.8K (-7.5%) | 5.21M +435.0K (+9.1%) | 1.75% -0.563 pp | 0.00% +0.000 pp | USD2.70 +41.1% | 20 qtrs — |
| 10 | GOLDMAN SACHS GROUP INC | 1.35M -227.8K (-14.5%) | 5.13M +45.6K (+0.9%) | 1.72% -0.740 pp | 0.00% +0.000 pp | USD3.59 +6.1% | 14 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.09M +70.8K (+6.9%) | 4.17M +862.9K (+26.1%) | 1.40% -0.201 pp | 0.00% +0.000 pp | USD5.98 -36.3% | 23 qtrs — |
| 12 | DAFNA CAPITAL MANAGEMENT LLC | 939.2K -88.6K (-8.6%) | 3.58M +258.5K (+7.8%) | 1.20% -0.406 pp | 0.83% +0.011 pp | USD4.10 -7.1% | 23 qtrs — |
| 13 | ALYESKA INVESTMENT GROUP, L.P. | 927.8K -959.3K (-50.8%) | 3.53M -2.6M (-42.0%) | 1.18% -1.763 pp | 0.01% -0.009 pp | USD4.51 -15.5% | 8 qtrs — |
| 14 | STATE STREET CORP | 911.9K +20.1K (+2.2%) | 3.47M +593.7K (+20.6%) | 1.16% -0.229 pp | 0.00% +0.000 pp | USD5.69 -33.0% | 19 qtrs — |
| 15 | WOODLINE PARTNERS LP | 800.9K -822.0K (-50.7%) | 3.05M -2.2M (-41.8%) | 1.02% -1.512 pp | 0.01% -0.013 pp | USD3.86 -1.3% | 14 qtrs — |
| 16 | JANE STREET GROUP, LLC | 678.9K +256.2K (+60.6%) | 2.59M +1.2M (+89.5%) | 0.87% +0.207 pp | 0.00% +0.000 pp | USD3.44 +10.8% | 8 qtrs — |
| 17 | VERITION FUND MANAGEMENT LLC | 567.7K +— (+0.0%) | 2.16M +329.3K (+18.0%) | 0.72% -0.162 pp | 0.01% +0.001 pp | USD4.49 -15.1% | 22 qtrs — |
| 18 | DRIEHAUS CAPITAL MANAGEMENT LLC | 535.5K +— (+0.0%) | 2.04M +310.6K (+18.0%) | 0.68% -0.153 pp | 0.01% +0.002 pp | USD6.02 -36.7% | 8 qtrs — |
| 19 | AQR CAPITAL MANAGEMENT LLC | 502.3K -60.2K (-10.7%) | 1.91M +97.0K (+5.3%) | 0.64% -0.237 pp | 0.00% 0.000 pp | USD2.82 +35.1% | 7 qtrs — |
| 20 | D. E. SHAW & CO., INC. | 437.4K +437.4K (+100.0%) | 1.67M +1.7M (+100.0%) | 0.56% +0.558 pp | 0.00% +0.001 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 21 | CAPTION MANAGEMENT, LLC | 415.3K -897.1K (-68.4%) | 1.58M -2.7M (-62.7%) | 0.53% -1.519 pp | 0.01% -0.022 pp | USD3.05 +24.9% | 3 qtrs — |
| 22 | FEDERATED HERMES, INC. | 358.9K +356.5K (+14,885.7%) | 1.37M +1.4M (+17,576.3%) | 0.46% +0.455 pp | 0.00% +0.002 pp | USD3.80 +0.3% | 3 qtrs — |
| 23 | NORTHERN TRUST CORP | 356.8K -21.5K (-5.7%) | 1.36M +137.4K (+11.2%) | 0.46% -0.135 pp | 0.00% +0.000 pp | USD4.84 -21.3% | 22 qtrs — |
| 24 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 344.2K +181.4K (+111.4%) | 1.31M +785.7K (+149.4%) | 0.44% +0.185 pp | 0.01% +0.005 pp | USD3.54 +7.6% | 2 qtrs — |
| 25 | DIMENSIONAL FUND ADVISORS LP | 327.5K +271.2K (+482.1%) | 1.25M +1.1M (+586.7%) | 0.42% +0.330 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 20 qtrs — |
| 26 | MAREX GROUP PLC | 312.0K +171.0K (+121.3%) | 1.19M +733.3K (+161.0%) | 0.40% +0.178 pp | 0.01% +0.004 pp | USD3.55 +7.3% | 2 qtrs — |
| 27 | RENAISSANCE TECHNOLOGIES LLC | 297.3K -561.4K (-65.4%) | 1.13M -1.6M (-59.2%) | 0.38% -0.962 pp | 0.00% -0.002 pp | USD3.88 -1.8% | 23 qtrs — |
| 28 | TWO SIGMA INVESTMENTS, LP | 295.2K +160.5K (+119.1%) | 1.12M +689.5K (+158.4%) | 0.38% +0.166 pp | 0.00% +0.001 pp | USD3.45 +10.4% | 18 qtrs — |
| 29 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 252.8K +181.4K (+253.9%) | 963.1K +732.4K (+317.5%) | 0.32% +0.211 pp | 0.00% +0.000 pp | USD3.62 +5.2% | 20 qtrs — |
| 30 | CERITY PARTNERS LLC | 234.7K -4.4K (-1.8%) | 894.3K +121.9K (+15.8%) | 0.30% -0.074 pp | 0.00% +0.000 pp | USD2.92 +30.5% | 3 qtrs — |
| 31 | ADAR1 CAPITAL MANAGEMENT, LLC | 185.7K -50.0K (-21.2%) | 707.5K -53.8K (-7.1%) | 0.24% -0.131 pp | 0.05% -0.020 pp | USD2.89 +31.8% | 3 qtrs — |
| 32 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 162.1K +— (+0.0%) | 617.7K +94.0K (+18.0%) | 0.21% -0.046 pp | 0.00% +0.000 pp | USD4.53 -15.9% | 13 qtrs — |
| 33 | MORGAN STANLEY | 136.0K +43.0K (+46.2%) | 518.1K +217.7K (+72.5%) | 0.17% +0.028 pp | 0.00% +0.000 pp | USD3.68 +3.5% | 23 qtrs — |
| 34 | XTX TOPCO LTD | 118.9K +66.6K (+127.1%) | 453.2K +284.0K (+167.9%) | 0.15% +0.070 pp | 0.01% +0.003 pp | USD3.40 +12.1% | 8 qtrs — |
| 35 | BANK OF NEW YORK MELLON CORP | 115.9K +4.9K (+4.4%) | 441.7K +83.0K (+23.1%) | 0.15% -0.025 pp | 0.00% +0.000 pp | USD6.01 -36.6% | 20 qtrs — |
| 36 | UBS GROUP AG | 114.6K -143.4K (-55.6%) | 436.5K -396.8K (-47.6%) | 0.15% -0.257 pp | 0.00% 0.000 pp | USD3.28 +16.2% | 17 qtrs — |
| 37 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111.2K +33.0K (+42.2%) | 423.7K +171.1K (+67.7%) | 0.14% +0.020 pp | 0.01% +0.004 pp | USD2.64 +44.3% | 4 qtrs — |
| 38 | NUVEEN, LLC | 105.2K +— (+0.0%) | 400.7K +61.0K (+18.0%) | 0.13% -0.030 pp | 0.00% +0.000 pp | USD2.32 +64.2% | 4 qtrs — |
| 39 | GSA CAPITAL PARTNERS LLP | 102.0K +20.6K (+25.3%) | 389.0K +126.0K (+47.9%) | 0.13% +0.003 pp | 0.03% +0.012 pp | USD3.08 +23.7% | 12 qtrs — |
| 40 | JUMP FINANCIAL, LLC | 96.1K +96.1K (+100.0%) | 366.0K +366.0K (+100.0%) | 0.12% +0.123 pp | 0.00% +0.005 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 41 | CANADA PENSION PLAN INVESTMENT BOARD | 94.0K +94.0K (+100.0%) | 358.1K +358.1K (+100.0%) | 0.12% +0.120 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 42 | TWO SIGMA ADVISERS, LP | 89.1K -163.2K (-64.7%) | 339.6K -475.6K (-58.3%) | 0.11% -0.280 pp | 0.00% -0.001 pp | USD2.83 +34.6% | 23 qtrs — |
| 43 | BARCLAYS PLC | 78.5K +18.4K (+30.7%) | 299.0K -94.2K (-24.0%) | 0.10% +0.006 pp | 0.00% +0.000 pp | USD4.50 -15.3% | 12 qtrs — |
| 44 | AMERICAN CENTURY COMPANIES INC | 75.5K -15.6K (-17.2%) | 287.8K -6.7K (-2.3%) | 0.10% -0.046 pp | 0.00% +0.000 pp | USD4.76 -20.0% | 10 qtrs — |
| 45 | ALLIANCEBERNSTEIN L.P. | 74.5K +— (+0.0%) | 284.0K +43.2K (+18.0%) | 0.10% -0.021 pp | 0.00% +0.000 pp | USD5.20 -26.7% | 7 qtrs — |
| 46 | ETHIC INC. | 68.1K -7.3K (-9.7%) | 259.5K +15.9K (+6.5%) | 0.09% -0.031 pp | 0.00% +0.000 pp | USD2.95 +29.2% | 3 qtrs — |
| 47 | ACADIAN ASSET MANAGEMENT LLC | 64.7K +64.7K (+100.0%) | 245.0K +245.0K (+100.0%) | 0.08% +0.083 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 48 | RHUMBLINE ADVISERS | 63.6K -5.3K (-7.7%) | 242.2K +19.7K (+8.9%) | 0.08% -0.026 pp | 0.00% +0.000 pp | USD5.01 -24.0% | 11 qtrs — |
| 49 | SCHONFELD STRATEGIC ADVISORS LLC | 61.8K +61.8K (+100.0%) | 235.3K +235.3K (+100.0%) | 0.08% +0.079 pp | 0.00% +0.001 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 50 | QUADRATURE CAPITAL LTD | 57.6K +38.1K (+195.4%) | 219.6K +156.7K (+249.0%) | 0.07% +0.043 pp | 0.00% +0.002 pp | USD3.61 +5.5% | 4 qtrs — |
| 51 | WELLS FARGO & COMPANY/MN | 56.9K +18.5K (+48.0%) | 216.8K +92.6K (+74.6%) | 0.07% +0.013 pp | 0.00% +0.000 pp | USD3.87 -1.6% | 13 qtrs — |
| 52 | ENTRYPOINT CAPITAL, LLC | 53.3K +53.3K (+100.0%) | 203.2K +203.2K (+100.0%) | 0.07% +0.068 pp | 0.08% +0.079 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 53 | IEQ CAPITAL, LLC | 49.2K -15.7K (-24.2%) | 187.3K -22.2K (-10.6%) | 0.06% -0.039 pp | 0.00% 0.000 pp | USD2.74 +39.1% | 4 qtrs — |
| 54 | PALE FIRE CAPITAL SE | 45.2K +— (+0.0%) | 172.3K +26.2K (+18.0%) | 0.06% -0.013 pp | 0.01% -0.004 pp | USD6.01 -36.6% | 10 qtrs — |
| 55 | GRAHAM CAPITAL MANAGEMENT, L.P. | 42.3K +42.3K (+100.0%) | 161.0K +161.0K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.004 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 56 | NEXT LEVEL PRIVATE LLC | 41.7K +— (+0.0%) | 158.9K -41.7K (-20.8%) | 0.05% -0.012 pp | 0.04% -0.017 pp | USD3.07 +24.1% | 3 qtrs — |
| 57 | J. GOLDMAN & CO LP | 40.5K -163.2K (-80.1%) | 154.3K -503.7K (-76.6%) | 0.05% -0.267 pp | 0.00% -0.013 pp | USD3.23 +18.0% | 2 qtrs — |
| 58 | BANK OF AMERICA CORP /DE/ | 40.5K +12.3K (+43.8%) | 154.2K +63.3K (+69.6%) | 0.05% +0.008 pp | 0.00% +0.000 pp | USD5.05 -24.6% | 13 qtrs — |
| 59 | MAN GROUP PLC | 39.2K +39.2K (+100.0%) | 149.4K +149.4K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 60 | JOURNEY STRATEGIC WEALTH LLC | 35.8K -20.0 (-0.1%) | 136.5K +20.7K (+17.9%) | 0.05% -0.010 pp | 0.00% +0.000 pp | USD3.13 +21.7% | 11 qtrs — |
| 61 | CREATIVE PLANNING | 35.6K -28.7K (-44.6%) | 135.7K -71.9K (-34.6%) | 0.05% -0.055 pp | 0.00% 0.000 pp | USD3.23 +18.0% | 2 qtrs — |
| 62 | DEUTSCHE BANK AG\ | 34.4K -20.6K (-37.5%) | 131.0K -46.6K (-26.2%) | 0.04% -0.042 pp | 0.00% +0.000 pp | USD4.23 -9.9% | 12 qtrs — |
| 63 | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 33.0K +— (+0.0%) | 125.7K +19.1K (+18.0%) | 0.04% -0.009 pp | 0.07% -0.027 pp | USD3.20 +19.1% | 5 qtrs — |
| 64 | CWM, LLC | 32.6K -3.4K (-9.4%) | 124.0K +8.0K (+6.9%) | 0.04% -0.015 pp | 0.00% +0.000 pp | USD2.70 +41.1% | 4 qtrs — |
| 65 | SIMPLEX TRADING, LLC | 30.5K -184.9K (-85.8%) | 116.3K -578.7K (-83.3%) | 0.04% -0.298 pp | 0.00% 0.000 pp | USD3.01 +26.6% | 3 qtrs — |
| 66 | SQUAREPOINT OPS LLC | 30.4K +30.4K (+100.0%) | 115.9K +115.9K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 67 | FI3 FINANCIAL ADVISORS, LLC | 29.3K +82.0 (+0.3%) | 111.7K +17.3K (+18.3%) | 0.04% -0.008 pp | 0.03% +0.002 pp | USD8.46 -55.0% | 20 qtrs — |
| 68 | PRICE T ROWE ASSOCIATES INC /MD/ | 29.0K +6.0K (+26.3%) | 111.0K +36.0K (+48.0%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD5.63 -32.3% | 7 qtrs — |
| 69 | WALLEYE TRADING LLC | 25.0K +— (+0.0%) | 95.3K +14.5K (+18.0%) | 0.03% -0.007 pp | 0.00% +0.000 pp | USD3.87 -1.6% | 5 qtrs — |
| 70 | JPMORGAN CHASE & CO | 24.9K -397.0 (-1.6%) | 94.7K +13.1K (+16.1%) | 0.03% -0.008 pp | 0.00% +0.000 pp | USD3.54 +7.6% | 19 qtrs — |
| 71 | COMMONWEALTH EQUITY SERVICES, LLC | 22.8K +22.8K (+100.0%) | 87.1K +87.1K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 72 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 22.5K +704.0 (+3.2%) | 85.9K +15.4K (+21.8%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD7.02 -45.7% | 7 qtrs — |
| 73 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 21.1K +21.1K (+100.0%) | 80.3K +80.3K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 74 | INTECH INVESTMENT MANAGEMENT LLC | 21.0K -252.0 (-1.2%) | 79.9K +11.3K (+16.6%) | 0.03% -0.006 pp | 0.00% +0.000 pp | USD3.88 -1.8% | 6 qtrs — |
| 75 | INVESCO LTD. | 18.4K +644.0 (+3.6%) | 70.1K +12.8K (+22.2%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD6.70 -43.1% | 9 qtrs — |
| 76 | AXQ CAPITAL, LP | 17.7K -20.1K (-53.3%) | 67.3K -54.7K (-44.9%) | 0.02% -0.037 pp | 0.02% -0.032 pp | USD3.05 +24.9% | 5 qtrs — |
| 77 | COLDSTREAM CAPITAL MANAGEMENT INC | 16.3K -1.2K (-6.8%) | 62.2K +5.6K (+9.9%) | 0.02% -0.007 pp | 0.00% +0.000 pp | USD3.23 +18.0% | 2 qtrs — |
| 78 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 16.0K +402.0 (+2.6%) | 60.8K +10.6K (+21.0%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD7.94 -52.0% | 7 qtrs — |
| 79 | SG AMERICAS SECURITIES, LLC | 15.8K +15.8K (+100.0%) | 60.0K +60.0K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 80 | CHERRY TREE WEALTH MANAGEMENT, LLC | 15.3K +2.0K (+15.1%) | 58.2K +15.3K (+35.7%) | 0.02% -0.001 pp | 0.01% +0.003 pp | USD3.07 +24.1% | 3 qtrs — |
| 81 | B.O.S.S. RETIREMENT ADVISORS, LLC | 14.4K +1.7K (+13.5%) | 55.0K +13.9K (+33.9%) | 0.02% -0.001 pp | 0.02% +0.008 pp | USD3.30 +15.5% | 2 qtrs — |
| 82 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 13.9K -1.1K (-7.0%) | 53.1K +4.7K (+9.7%) | 0.02% -0.006 pp | 0.00% +0.000 pp | USD3.77 +1.1% | 5 qtrs — |
| 83 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 15.6K -2.6K (-14.4%) | 52.6K -33.5K (-38.9%) | 0.02% -0.009 pp | 0.00% 0.000 pp | USD2.98 +27.9% | 3 qtrs — |
| 84 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 13.7K +— (+0.0%) | 52.3K +8.0K (+18.0%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD3.65 +4.4% | 5 qtrs — |
| 85 | METLIFE INVESTMENT MANAGEMENT, LLC | 13.6K -12.1K (-47.1%) | 51.8K -31.2K (-37.6%) | 0.02% -0.023 pp | 0.00% 0.000 pp | USD2.89 +31.8% | 8 qtrs — |
| 86 | KEYSTONE FINANCIAL GROUP | 13.0K +— (+0.0%) | 49.5K +12.0K (+31.8%) | 0.02% -0.004 pp | 0.00% +0.001 pp | USD2.89 +31.8% | 3 qtrs — |
| 87 | FMR LLC | 12.9K -1.5K (-10.3%) | 49.1K +2.7K (+5.9%) | 0.02% -0.006 pp | 0.00% +0.000 pp | USD3.39 +12.4% | 11 qtrs — |
| 88 | PROSHARE ADVISORS LLC | 12.6K +1.5K (+13.8%) | 48.1K +12.3K (+34.3%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD3.86 -1.3% | 5 qtrs — |
| 89 | BNP PARIBAS ARBITRAGE, SNC | 12.6K +2.4K (+23.7%) | 47.8K +15.1K (+45.9%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD3.49 +9.2% | 5 qtrs — |
| 90 | TWO SIGMA SECURITIES, LLC | 12.4K +12.4K (+100.0%) | 47.2K +47.2K (+100.0%) | 0.02% +0.016 pp | 0.01% +0.007 pp | USD3.81 +0.0% | 1 qtrs NEW |
| 91 | PRELUDE CAPITAL MANAGEMENT, LLC | 10.9K +— (+0.0%) | 41.4K +6.3K (+18.0%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD2.89 +31.8% | 3 qtrs — |
| 92 | SEI INVESTMENTS CO | 10.6K +— (+0.0%) | 40.3K +6.1K (+18.0%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD6.55 -41.8% | 6 qtrs — |
| 93 | PALLAS CAPITAL ADVISORS LLC | 10.2K -608.0 (-5.6%) | 38.7K +3.9K (+11.3%) | 0.01% -0.004 pp | 0.00% +0.000 pp | USD3.23 +18.0% | 2 qtrs — |
| 94 | OPPENHEIMER & CO INC | 10.0K +— (+0.0%) | 38.1K +5.8K (+18.0%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD2.89 +31.8% | 3 qtrs — |
| 95 | STRS OHIO | 7.9K +— (+0.0%) | 30.1K +4.6K (+18.0%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD4.56 -16.4% | 11 qtrs — |
| 96 | NEW YORK STATE COMMON RETIREMENT FUND | 6.6K +— (+0.0%) | 25.2K +3.8K (+18.0%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD3.14 +21.3% | 11 qtrs — |
| 97 | TOWER RESEARCH CAPITAL LLC (TRC) | 6.5K +2.2K (+52.4%) | 24.9K +11.0K (+79.7%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD3.68 +3.5% | 23 qtrs — |
| 98 | CITIGROUP INC | 6.5K +1.2K (+23.0%) | 24.7K +7.7K (+45.1%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD5.23 -27.2% | 21 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 58 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco Russell 2000 Dynamic Multifactor ETF OMFS | 0.14% | 399.9K | 0.39% |
| 2 | Federated Hermes MDT Small Cap Core ETF FSCC | 0.11% | 181.8K | 0.51% |
| 3 | iShares Micro-Cap ETF IWC | 0.06% | 957.1K | 0.60% |
| 4 | Fidelity Enhanced Small Cap ETF FESM | 0.06% | 3.18M | 0.28% |
| 5 | Vanguard Global Momentum Factor ETF VMO.TO | 0.05% | 188.3K | 0.38% |
| 6 | Vanguard U.S. Momentum Factor ETF VFMO | 0.04% | 761.2K | 0.13% |
| 7 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.03% | 359.9K | 0.35% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.03% | 24.1K | 0.35% |
| 9 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.03% | 141.5K | 0.40% |
| 10 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.03% | 22.8K | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
8
Sells
0
Shares acquired
1.32M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,322,844
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | THOMAS FRANK E | Director | P-Purchase | A | Common Stock | 5,000 | 5.00 | 25.0K | 7,000 | D | ↗ |
| 2026-02-27 | SHERMAN JEFFREY W | Director | P-Purchase | A | Common Stock | 5,000 | 5.00 | 25.0K | 5,000 | D | ↗ |
| 2026-02-27 | Hamilton Thomas Edward | Director | P-Purchase | A | Common Stock | 100,000 | 5.00 | 500.0K | 664,798 | D | ↗ |
| 2026-02-27 | Flynn James E | Director / 10% Owner | P-Purchase | A | Common Stock | 1,084,012 | 5.00 | 5.42M | 10,622,957 | I | ↗ |
| 2026-01-26 | Shankar Gopi | Officer | A-Award | A | Common Stock | 25,637 | 0.00 | — | 76,443 | D | ↗ |
| 2026-01-26 | Clayton Russell | Officer | A-Award | A | Stock Option (Right to Buy) | 153,822 | 3.60 | 553.8K | 153,822 | D | ↗ |
| 2026-01-26 | Celano Michael | Officer | A-Award | A | Common Stock | 37,604 | 0.00 | — | 215,785 | D | ↗ |
| 2026-01-26 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 600,600 | 3.60 | 2.16M | 600,600 | D | ↗ |
| 2025-07-31 | Flynn James E | Director / 10% Owner | P-Purchase | A | Common Stock | 3,387,539 | 3.20 | 10.84M | 9,538,945 | I | ↗ |
| 2025-05-13 | Truitt Joseph | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 1.88 | 35.6K | 19,000 | D | ↗ |
| 2025-05-13 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 1.88 | 35.6K | 19,000 | D | ↗ |
| 2025-05-13 | SHERMAN JEFFREY W | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 1.88 | 35.6K | 19,000 | D | ↗ |
| 2025-05-13 | LEFF JONATHAN S | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 1.88 | 35.6K | 19,000 | D | ↗ |
| 2025-05-13 | Hamilton Thomas Edward | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 1.88 | 35.6K | 19,000 | D | ↗ |
| 2025-05-13 | Flynn James E | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 19,000 | 1.88 | 35.6K | 19,000 | I | ↗ |
| 2025-01-22 | Shankar Gopi | Officer | A-Award | A | Stock Option (Right to Buy) | 139,838 | 3.46 | 483.8K | 139,838 | D | ↗ |
| 2025-01-22 | Clayton Russell | Officer | A-Award | A | Stock Option (Right to Buy) | 139,838 | 3.46 | 483.8K | 139,838 | D | ↗ |
| 2025-01-22 | Celano Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 205,111 | 3.46 | 709.7K | 205,111 | D | ↗ |
| 2025-01-22 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 546,000 | 3.46 | 1.89M | 546,000 | D | ↗ |
| 2024-05-29 | Truitt Joseph | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.07 | 134.3K | 19,000 | — | ↗ |
| 2024-05-29 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.07 | 134.3K | 19,000 | — | ↗ |
| 2024-05-29 | SHERMAN JEFFREY W | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.07 | 134.3K | 19,000 | — | ↗ |
| 2024-05-29 | LEFF JONATHAN S | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.07 | 134.3K | 19,000 | — | ↗ |
| 2024-05-29 | Hamilton Thomas Edward | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.07 | 134.3K | 19,000 | — | ↗ |
| 2024-05-29 | Flynn James E | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.07 | 134.3K | 19,000 | — | ↗ |
| 2024-02-16 | Hamilton Thomas Edward | Director | P-Purchase | A | Common Stock | 57,208 | 8.74 | 500.0K | 564,798 | — | ↗ |
| 2024-02-16 | Flynn James E | Director / 10% Owner | P-Purchase | A | Common Stock | 1,430,206 | 8.74 | 12.50M | 6,151,406 | — | ↗ |
| 2024-02-14 | THOMAS FRANK E | Director | P-Purchase | A | Common Stock | 2,000 | 11.00 | 22.0K | 2,000 | — | ↗ |
| 2024-01-17 | Shankar Gopi | Officer | A-Award | A | Common Stock | 22,500 | 0.00 | — | 27,500 | — | ↗ |
| 2024-01-17 | Clayton Russell | Officer | A-Award | A | Stock Option (Right to Buy) | 135,000 | 4.21 | 568.4K | 135,000 | — | ↗ |
| 2024-01-17 | Celano Michael | Officer | A-Award | A | Common Stock | 31,250 | 0.00 | — | 143,996 | — | ↗ |
| 2024-01-17 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Common Stock | 66,125 | 0.00 | — | 332,954 | — | ↗ |
| 2023-12-07 | Shankar Gopi | Officer | P-Purchase | A | Common Stock | 5,000 | 3.73 | 18.7K | 5,000 | — | ↗ |
| 2023-10-03 | SHERMAN JEFFREY W | Director | A-Award | A | Stock Option (Right to Buy) | 16,600 | 3.56 | 59.0K | 16,600 | — | ↗ |
| 2023-07-17 | Clayton Russell | Officer | A-Award | A | Stock Option (Right to Buy) | 180,000 | 3.22 | 579.6K | 180,000 | — | ↗ |
| 2023-05-17 | Truitt Joseph | Director | P-Purchase | A | Common Stock | 2,750 | 3.73 | 10.3K | 2,750 | — | ↗ |
| 2023-05-17 | Celano Michael | Officer | P-Purchase | A | Common Stock | 5,000 | 3.73 | 18.6K | 112,746 | — | ↗ |
| 2023-05-17 | BEN-MAIMON CAROLE | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 3.71 | 18.5K | 266,829 | — | ↗ |
| 2023-05-09 | Truitt Joseph | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 5.09 | 42.2K | 8,300 | — | ↗ |
| 2023-05-09 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 5.09 | 42.2K | 8,300 | — | ↗ |
| 2023-05-09 | LEFF JONATHAN S | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 5.09 | 42.2K | 8,300 | — | ↗ |
| 2023-05-09 | Hamilton Thomas Edward | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 5.09 | 42.2K | 8,300 | — | ↗ |
| 2023-05-09 | Flynn James E | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 8,300 | 5.09 | 42.2K | 8,300 | — | ↗ |
| 2023-02-07 | Shankar Gopi | Officer | A-Award | A | Stock Option (Right to Buy) | 180,000 | 5.88 | 1.06M | 180,000 | — | ↗ |
| 2023-01-31 | Celano Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 120,000 | 4.94 | 592.8K | 120,000 | — | ↗ |
| 2023-01-31 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 325,000 | 4.94 | 1.61M | 325,000 | — | ↗ |
| 2022-09-16 | Hamilton Thomas Edward | Director | P-Purchase | A | Common Stock | 317,460 | 3.15 | 1,000.0K | 507,590 | — | ↗ |
| 2022-09-16 | Flynn James E | Director / 10% Owner | P-Purchase | A | Common Stock | 2,777,777 | 3.15 | 8.75M | 4,721,183 | — | ↗ |
| 2022-09-16 | DEERFIELD PARTNERS, L.P. | Director / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,777,777 | — | ↗ |
| 2022-09-16 | Celano Michael | Officer | P-Purchase | A | Common Stock | 31,746 | 3.15 | 100.0K | 31,746 | — | ↗ |
| 2022-09-16 | BEN-MAIMON CAROLE | Director / Officer | P-Purchase | A | Common Stock | 31,746 | 3.15 | 100.0K | 56,829 | — | ↗ |
| 2022-05-10 | Truitt Joseph | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 0.00 | — | 8,300 | — | ↗ |
| 2022-05-10 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 0.00 | — | 8,300 | — | ↗ |
| 2022-05-10 | LEFF JONATHAN S | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 0.00 | — | 8,300 | — | ↗ |
| 2022-05-10 | Hamilton Thomas Edward | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 0.00 | — | 8,300 | — | ↗ |
| 2022-05-10 | Flynn James E | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 8,300 | 2.92 | 24.2K | 8,300 | — | ↗ |
| 2022-05-10 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 0.00 | — | 8,300 | — | ↗ |
| 2022-05-10 | Celano Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 20,000 | 2.92 | 58.4K | 20,000 | — | ↗ |
| 2022-05-10 | Barrett Peter | Director | A-Award | A | Stock Option (Right to Buy) | 8,300 | 0.00 | — | 8,300 | — | ↗ |
| 2022-05-10 | BEN-MAIMON CAROLE | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2022-01-18 | Celano Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 8.75 | 700.0K | 80,000 | — | ↗ |
| 2022-01-18 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 182,000 | 8.75 | 1.59M | 182,000 | — | ↗ |
| 2021-06-30 | Hamilton Thomas Edward | Director | P-Purchase | A | Common Stock | 56,710 | 8.75 | 496.2K | 190,130 | — | ↗ |
| 2021-06-30 | Flynn James E | Director / 10% Owner | P-Purchase | A | Common Stock | 228,571 | 8.75 | 2.00M | 1,943,423 | — | ↗ |
| 2021-05-12 | Truitt Joseph | Director | A-Award | A | Stock Option (right to buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-05-12 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-05-12 | LEFF JONATHAN S | Director | A-Award | A | Stock Option (right to buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-05-12 | Hamilton Thomas Edward | Director | A-Award | A | Stock Option (right to buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-05-12 | Flynn James E | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-05-12 | Daniel Thomas O | Director | A-Award | A | Stock Option (right to buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-05-12 | Barrett Peter | Director | A-Award | A | Stock Option (right to buy) | 8,300 | 10.34 | 85.8K | 8,300 | — | ↗ |
| 2021-01-19 | Celano Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 42,000 | 19.61 | 823.6K | 42,000 | — | ↗ |
| 2021-01-19 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 106,700 | 19.61 | 2.09M | 106,700 | — | ↗ |
| 2020-09-29 | Truitt Joseph | Director | A-Award | A | Stock Option (right to buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | LEFF JONATHAN S | Director | A-Award | A | Stock Option (right to buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | Hamilton Thomas Edward | Director | A-Award | A | Stock Option (right to buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | Flynn James E | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | Daniel Thomas O | Director | A-Award | A | Stock Option (right to buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | Celano Michael | Officer | A-Award | A | Stock Option (right to buy) | 84,100 | 11.90 | 1.00M | 84,100 | — | ↗ |
| 2020-09-29 | Barrett Peter | Director | A-Award | A | Stock Option (right to buy) | 16,600 | 11.90 | 197.5K | 16,600 | — | ↗ |
| 2020-09-29 | BEN-MAIMON CAROLE | Director / Officer | A-Award | A | Stock Option (right to buy) | 411,400 | 11.90 | 4.90M | 411,400 | — | ↗ |
| 2020-06-26 | Hamilton Thomas Edward | Director | J-Other | A | Common Stock | 159,433 | 0.00 | — | 292,853 | — | ↗ |
| 2020-06-26 | CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 10% Owner | J-Other | D | Common Stock | 6,091,242 | 0.00 | — | 8 | — | ↗ |
| 2020-06-26 | BEN-MAIMON CAROLE | Director / Officer | J-Other | A | Common Stock | 25,083 | 0.00 | — | 25,083 | — | ↗ |
| 2020-05-28 | Truitt Joseph | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-05-28 | LEFF JONATHAN S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-05-28 | Hamilton Thomas Edward | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-05-28 | Flynn James E | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 6,091,250 | — | ↗ |
| 2020-05-28 | Celano Michael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-05-28 | CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 6,091,250 | — | ↗ |
| 2020-05-28 | BEN-MAIMON CAROLE | Director / Officer | — | D | Stock Option (Right to Buy) | 61,419 | 11.73 | 720.4K | 0 | — | ↗ |
| 2019-06-26 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-06-26 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-06-26 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-06-26 | LAMATTINA JOHN L | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-06-26 | EVERETT WENDY | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-06-26 | Daniel Thomas O | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-06-26 | Barrett Peter | Director | A-Award | A | Stock Option (Right to Buy) | 27,000 | 1.25 | 33.8K | 27,000 | — | ↗ |
| 2019-04-02 | Singhal Priya | Officer | A-Award | A | Stock Option (Right to Buy) | 375,000 | 2.89 | 1.08M | 375,000 | — | ↗ |
| 2019-03-04 | Singhal Priya | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-01-24 | PEREZ ROBERT J | Director | A-Award | A | Common Stock | 4,423 | 4.38 | 19.4K | 5,322 | — | ↗ |
| 2019-01-24 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 11,804 | 4.38 | 51.7K | 11,804 | — | ↗ |
| 2019-01-24 | LAMATTINA JOHN L | Director | A-Award | A | Common Stock | 10,844 | 4.38 | 47.5K | 31,376 | — | ↗ |
| 2019-01-24 | Daniel Thomas O | Director | A-Award | A | Stock Option (Right to Buy) | 13,280 | 4.38 | 58.2K | 13,280 | — | ↗ |
| 2019-01-24 | Barrett Peter | Director | A-Award | A | Stock Option (Right to Buy) | 21,396 | 4.38 | 93.7K | 21,396 | — | ↗ |
| 2019-01-22 | McVeigh Brian | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 4.63 | 578.8K | 125,000 | — | ↗ |
| 2019-01-22 | KIM DENNIS D | Officer | A-Award | A | Stock Option (Right to Buy) | 95,000 | 4.63 | 439.9K | 95,000 | — | ↗ |
| 2019-01-22 | Hatfield Jeffrey S. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 525,000 | 4.63 | 2.43M | 525,000 | — | ↗ |
| 2019-01-22 | Allen Patricia L | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 4.63 | 578.8K | 125,000 | — | ↗ |
| 2018-06-29 | Atlas Venture Fund VII L P | 10% Owner | J-Other | D | Common Stock | 1,126,546 | 0.00 | — | 3,506,184 | — | ↗ |
| 2018-06-28 | Hughes Thomas E. | Director / Officer | S-Sale | D | Common Stock | 32,000 | 10.00 | 320.0K | 125,247 | — | ↗ |
| 2018-06-06 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 6.79 | 135.8K | 20,000 | — | ↗ |
| 2018-06-06 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 6.79 | 135.8K | 20,000 | — | ↗ |
| 2018-06-06 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 6.79 | 135.8K | 20,000 | — | ↗ |
| 2018-06-06 | LAMATTINA JOHN L | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 6.79 | 135.8K | 20,000 | — | ↗ |
| 2018-06-06 | EVERETT WENDY | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-06-06 | Daniel Thomas O | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 6.79 | 135.8K | 20,000 | — | ↗ |
| 2018-06-06 | Barrett Peter | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 20,000 | 6.79 | 135.8K | 20,000 | — | ↗ |
| 2018-05-29 | McVeigh Brian | Officer | A-Award | A | Stock Option (Right to Buy) | 225,000 | 6.46 | 1.45M | 225,000 | — | ↗ |
| 2018-03-07 | Hughes Thomas E. | Director / Officer | S-Sale | D | Common Stock | 5,000 | 10.00 | 50.0K | 157,247 | — | ↗ |
| 2018-02-22 | KIM DENNIS D | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 7.77 | 971.3K | 125,000 | — | ↗ |
| 2018-02-22 | Hughes Thomas E. | Director / Officer | A-Award | A | Stock Option (right to buy) | 275,000 | 7.77 | 2.14M | 275,000 | — | ↗ |
| 2018-02-22 | Hatfield Jeffrey S. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 275,000 | 7.77 | 2.14M | 275,000 | — | ↗ |
| 2018-02-22 | Allen Patricia L | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 7.77 | 971.3K | 125,000 | — | ↗ |
| 2018-01-03 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 9,421 | 5.18 | 48.8K | 9,421 | — | ↗ |
| 2018-01-03 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 9,725 | 5.18 | 50.4K | 9,725 | — | ↗ |
| 2018-01-03 | LAMATTINA JOHN L | Director | A-Award | A | Common Stock | 9,169 | 5.18 | 47.5K | 20,532 | — | ↗ |
| 2018-01-03 | Daniel Thomas O | Director | A-Award | A | Common Stock | 8,687 | 5.18 | 45.0K | 19,452 | — | ↗ |
| 2018-01-03 | Booth Bruce | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 8,509 | 5.18 | 44.1K | 8,509 | — | ↗ |
| 2018-01-03 | Barrett Peter | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 17,627 | 5.18 | 91.3K | 17,627 | — | ↗ |
| 2017-12-29 | Hatfield Jeffrey S. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,100,000 | 3.40 | 3.74M | 1,100,000 | — | ↗ |
| 2017-10-13 | Heller Frances K | Director | P-Purchase | A | Common Stock | 10,000 | 3.90 | 39.0K | 47,961 | — | ↗ |
| 2017-10-09 | Hughes Thomas E. | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 275,000 | 3.40 | 935.0K | 275,000 | — | ↗ |
| 2017-10-09 | Hatfield Jeffrey S. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 550,000 | 3.40 | 1.87M | 550,000 | — | ↗ |
| 2017-07-11 | KIM DENNIS D | Officer | P-Purchase | A | Common Stock | 10,000 | 3.39 | 33.9K | 21,443 | — | ↗ |
| 2017-06-21 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | LAMATTINA JOHN L | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | Heller Frances K | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | Daniel Thomas O | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | Booth Bruce | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-06-21 | Barrett Peter | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 14,500 | 3.95 | 57.3K | 14,500 | — | ↗ |
| 2017-05-11 | KIM DENNIS D | Officer | P-Purchase | A | Common Stock | 9,800 | 4.40 | 43.1K | 11,443 | — | ↗ |
| 2017-05-11 | Hughes Thomas E. | Director / Officer | M-Exempt | D | Stock Option (Right to Buy | 18,928 | 0.75 | 14.2K | 0 | — | ↗ |
| 2017-05-10 | KIM DENNIS D | Officer | P-Purchase | A | Common Stock | 200 | 4.40 | 880.00 | 1,643 | — | ↗ |
| 2017-02-13 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 13,289 | 4.18 | 55.5K | 13,289 | — | ↗ |
| 2017-02-13 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 13,718 | 4.18 | 57.3K | 13,718 | — | ↗ |
| 2017-02-13 | LAMATTINA JOHN L | Director | A-Award | A | Common Stock | 11,363 | 4.18 | 47.5K | 11,363 | — | ↗ |
| 2017-02-13 | Daniel Thomas O | Director | A-Award | A | Common Stock | 10,765 | 4.18 | 45.0K | 10,765 | — | ↗ |
| 2017-02-13 | Booth Bruce | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 12,003 | 4.18 | 50.2K | 12,003 | — | ↗ |
| 2017-02-13 | Barrett Peter | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 24,864 | 4.18 | 103.9K | 24,864 | — | ↗ |
| 2017-01-27 | KIM DENNIS D | Officer | A-Award | A | Stock Option (Right to Buy) | 88,000 | 4.05 | 356.4K | 88,000 | — | ↗ |
| 2017-01-27 | Hughes Thomas E. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 319,000 | 4.05 | 1.29M | 319,000 | — | ↗ |
| 2017-01-27 | Allen Patricia L | Officer | A-Award | A | Stock Option (Right to Buy) | 88,000 | 4.05 | 356.4K | 88,000 | — | ↗ |
| 2016-12-19 | Heller Frances K | Director | P-Purchase | A | Common Stock | 10,000 | 3.23 | 32.3K | 30,000 | — | ↗ |
| 2016-11-15 | Heller Frances K | Director | P-Purchase | A | Common Stock | 10,000 | 3.54 | 35.4K | 20,000 | — | ↗ |
| 2016-08-29 | Hughes Thomas E. | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 3.00 | 30.0K | 63,936 | — | ↗ |
| 2016-07-26 | Allen Patricia L | Officer | P-Purchase | A | Common Stock | 8,200 | 3.15 | 25.8K | 19,793 | — | ↗ |
| 2016-07-25 | Allen Patricia L | Officer | P-Purchase | A | Common Stock | 7,800 | 3.08 | 24.0K | 11,593 | — | ↗ |
| 2016-07-22 | Hughes Thomas E. | Director / Officer | M-Exempt | A | Common Stock | 25,000 | 0.75 | 18.8K | 48,936 | — | ↗ |
| 2016-07-22 | Heller Frances K | Director | P-Purchase | A | Common Stock | 10,000 | 2.99 | 29.9K | 10,000 | — | ↗ |
| 2016-07-20 | Flynn James E | 10% Owner | S-Sale | D | Common Stock | 193,630 | 3.31 | 641.3K | 247,413 | — | ↗ |
| 2016-06-30 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | LAMATTINA JOHN L | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | Heller Frances K | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | Daniel Thomas O | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | Booth Bruce | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-06-30 | Barrett Peter | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 5.99 | 71.9K | 12,000 | — | ↗ |
| 2016-04-01 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 6,100 | 7.91 | 48.3K | 6,100 | — | ↗ |
| 2016-04-01 | Daniel Thomas O | Director | A-Award | A | Stock Option (Right to Buy) | 3,841 | 6.70 | 25.7K | 3,841 | — | ↗ |
| 2016-03-31 | Secor Alicia | Officer | A-Award | D | Stock Option (Right to Buy) | 53,000 | 6.68 | 354.0K | 53,000 | — | ↗ |
| 2016-03-31 | Loustau Patrick | Officer | A-Award | A | Stock Option (Right to Buy) | 56,500 | 6.68 | 377.4K | 56,500 | — | ↗ |
| 2016-03-31 | KIM DENNIS D | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 6.68 | 501.0K | 75,000 | — | ↗ |
| 2016-03-31 | Hughes Thomas E. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 249,000 | 6.68 | 1.66M | 249,000 | — | ↗ |
| 2016-03-31 | Allen Patricia L | Officer | A-Award | A | Stock Option (Right to Buy) | 72,000 | 6.68 | 481.0K | 72,000 | — | ↗ |
| 2016-03-03 | Daniel Thomas O | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-02-12 | Flynn James E | 10% Owner | P-Purchase | A | Common Stock | 13,872 | 6.25 | 86.7K | 2,053,232 | — | ↗ |
| 2016-02-11 | Flynn James E | 10% Owner | P-Purchase | A | Common Stock | 504 | 6.19 | 3.1K | 2,039,360 | — | ↗ |
| 2016-02-10 | Flynn James E | 10% Owner | P-Purchase | A | Common Stock | 32,501 | 6.23 | 202.6K | 2,038,856 | — | ↗ |
| 2016-02-09 | Flynn James E | 10% Owner | P-Purchase | A | Common Stock | 24,484 | 5.73 | 140.3K | 2,006,355 | — | ↗ |
| 2016-01-25 | McDonough Cameron Geoffrey | Director | A-Award | A | Common Stock | 4,424 | 7.91 | 35.0K | 4,424 | — | ↗ |
| 2016-01-25 | LAMATTINA JOHN L | Director | A-Award | A | Stock Option (Right to Buy) | 9,150 | 7.91 | 72.4K | 9,150 | — | ↗ |
| 2016-01-25 | Booth Bruce | Director / 10% Owner | A-Award | A | Common Stock | 4,424 | 7.91 | 35.0K | 4,638,028 | — | ↗ |
| 2016-01-25 | Barrett Peter | Director / 10% Owner | A-Award | A | Common Stock | 8,849 | 7.91 | 70.0K | 4,643,327 | — | ↗ |
| 2016-01-08 | Hughes Thomas E. | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 0.75 | 7.5K | 43,928 | — | ↗ |
| 2016-01-07 | PEREZ ROBERT J | Director | A-Award | A | Common Stock | 5,564 | 6.29 | 35.0K | 5,564 | — | ↗ |
| 2015-10-28 | PEREZ ROBERT J | Director | A-Award | A | Common Stock | 899 | 10.45 | 9.4K | 899 | — | ↗ |
| 2015-10-28 | McDonough Cameron Geoffrey | Director | A-Award | A | Stock Option (Right to Buy) | 1,207 | 10.45 | 12.6K | 1,207 | — | ↗ |
| 2015-09-24 | STARR KEVIN P | Director | S-Sale | D | Common Stock | 61,630 | 44.10 | 2.72M | 210,371 | — | ↗ |
| 2015-09-24 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 24,000 | 40.56 | 973.4K | 24,000 | — | ↗ |
| 2015-09-24 | McDonough Cameron Geoffrey | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-09-23 | Hughes Thomas E. | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,500 | 0.75 | 7.9K | 53,928 | — | ↗ |
| 2015-09-18 | Hughes Thomas E. | Director / Officer | S-Sale | D | Common Stock | 23,126 | 45.00 | 1.04M | 820 | — | ↗ |
| 2015-09-18 | Goldberg Avi Y. | Director | S-Sale | D | Common Stock | 5,000 | 45.00 | 225.0K | 53,734 | — | ↗ |
| 2015-09-17 | Secor Alicia | Officer | M-Exempt | A | Common Stock | 25,000 | 9.67 | 241.8K | 26,256 | — | ↗ |
| 2015-09-17 | KIM DENNIS D | Officer | S-Sale | D | Common Stock | 9,142 | 40.00 | 365.7K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
85.58M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2019 | Jeffrey S. Hatfield Former Chief Executive Officer | 536.1K | 804.2K | — | 1.91M | — | 8.4K | 3.24M | 59.13% | ↗ |
| 2 | 2019 | Priya Singhal | 360.9K | 174.0K | — | 855.4K | — | 8.4K | 1.40M | 61.16% | ↗ |
| 3 | 2019 | Brian P. McVeigh Former Chief Business Officer | 408.2K | 219.3K | — | 455.7K | — | 8.4K | 1.09M | 41.75% | ↗ |
| 4 | 2018 | Jeffrey S. Hatfield Chief Executive Officer | 518.0K | — | — | 1.72M | 155.4K | 75.2K | 2.47M | 69.68% | ↗ |
| 5 | 2018 | Jeffrey S. Hatfield Former Chief Executive Officer | 518.0K | — | — | 1.72M | 155.4K | 75.2K | 2.47M | 69.68% | ↗ |
| 6 | 2018 | Thomas E. Hughes, Ph.D. President and Chief Scientific Officer | 367.8K | — | — | 1.72M | — | 8.3K | 2.10M | 82.06% | ↗ |
| 7 | 2018 | Brian P. McVeigh Former Chief Business Officer | 237.5K | — | — | 1.16M | 56.0K | 7.1K | 1.46M | 79.45% | ↗ |
| 8 | 2018 | Brian P. McVeigh Former Chief Business Officer | 237.5K | — | — | 1.16M | 56.0K | 7.1K | 1.46M | 79.45% | ↗ |
| 9 | 2018 | Dennis D. Kim, M.D., M.B.A. Chief Medical Officer | 409.0K | — | — | 782.0K | 85.9K | 8.3K | 1.29M | 60.85% | ↗ |
| 10 | 2017 | Jeffrey S. Hatfield Chief Executive Officer | 114.6K | 100.0K | — | 4.26M | 48.2K | 4.3K | 4.53M | 94.10% | ↗ |
| 11 | 2017 | Jeffrey S. Hatfield Chief Executive Officer | 114.6K | 100.0K | — | — | 48.2K | 4.3K | 4.53M | 0.00% | ↗ |
| 12 | 2017 | Thomas E. Hughes, Ph.D. President and Chief Scientific Officer | 480.0K | — | — | 1.35M | 222.0K | 5.4K | 2.05M | 65.56% | ↗ |
| 13 | 2017 | Dennis D. Kim, M.D., M.B.A. Chief Medical Officer | 392.0K | — | — | 261.5K | 126.9K | 5.4K | 785.8K | 33.28% | ↗ |
| 14 | 2017 | Patricia L. Allen Chief Financial Officer | 331.0K | — | — | — | 107.2K | 5.4K | 705.1K | 0.00% | ↗ |
| 15 | 2016 | Thomas E. Hughes, Ph.D. President and Chief Scientific Officer | 463.5K | — | — | — | 197.0K | 5.3K | 2.50M | 0.00% | ↗ |
| 16 | 2016 | Thomas E. Hughes, Ph.D. President and Chief Executive Officer | 463.5K | — | — | 1.84M | 197.0K | 5.3K | 2.50M | 73.38% | ↗ |
| 17 | 2016 | Dennis D. Kim, M.D., M.B.A. Chief Medical Officer | 378.5K | — | — | — | 112.6K | 5.3K | 1.05M | 0.00% | ↗ |
| 18 | 2016 | Dennis D. Kim, M.D., M.B.A Chief Medical Officer | 378.5K | — | — | 552.8K | 112.6K | 5.3K | 1.05M | 52.68% | ↗ |
| 19 | 2016 | Patricia L. Allen Chief Financial Officer | 320.0K | — | — | — | 95.2K | 5.3K | 951.2K | 0.00% | ↗ |
| 20 | 2015 | Thomas E. Hughes, Ph.D. President and Chief Executive Officer | 450.0K | — | — | 5.97M | — | 5.3K | 6.42M | 92.91% | ↗ |
| 21 | 2015 | Thomas E. Hughes, Ph.D. Chief Executive Officer | 450.0K | — | — | 5.97M | — | 5.3K | 6.42M | 92.91% | ↗ |
| 22 | 2015 | Dennis D. Kim, M.D., M.B.A Chief Medical Officer | 367.5K | — | — | 2.54M | — | 5.3K | 2.91M | 87.20% | ↗ |
| 23 | 2015 | Alicia Secor Chief Commercial Officer | 340.0K | — | — | 1.69M | — | 5.3K | 2.04M | 83.06% | ↗ |
| 24 | 2015 | Patricia L. Allen Chief Financial Officer | 307.5K | — | — | 1.69M | — | 5.3K | 2.01M | 84.41% | ↗ |
| 25 | 2014 | Patrick Loustau | 195.4K | — | — | 3.38M | 70.0K | 29.3K | 3.67M | 91.98% | ↗ |
| 26 | 2014 | Alicia Secor Chief Commercial Officer | 328.8K | — | — | 1.16M | 99.0K | 5.2K | 1.59M | 72.85% | ↗ |
| 27 | 2014 | Alicia Secor Chief Commercial Officer | 328.8K | — | — | 1.16M | 99.0K | 5.2K | 1.59M | 72.85% | ↗ |
| 28 | 2014 | Thomas E. Hughes, Ph.D. Chief Executive Officer | 425.0K | — | — | — | 178.5K | 5.2K | 608.7K | 0.00% | ↗ |
| 29 | 2014 | Dennis D. Kim, M.D., M.B.A Chief Medical Officer | 350.0K | — | — | — | 126.0K | 5.2K | 481.2K | 0.00% | ↗ |
| 30 | 2013 | Thomas E. Hughes, Ph.D. Chief Executive Officer | 400.0K | — | — | 592.0K | 120.0K | 5.1K | 1.12M | 52.99% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carole S. Ben-Maimon | Chief Executive Officer, President & Director | 976.4K | — |
| Michael Celano | Secretary & Chief Financial Officer | 697.0K | male |
| Gopi Shankar | Chief Development Officer | 642.4K | — |
| Russell G. Clayton | Chief Medical Officer | — | — |
| Jennifer Spokes Johansson | Vice President of Legal & Compliance | — | female |
| Francis Michael Conway | Vice President & Controller | — | male |
| John Berman | Vice President of Finance & Administration | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LRMR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
